Infiltration of CD8+ T lymphocytes that has been shown to predict a favorable prognosis in several tumor types40–43 was associated only with a non-statistically significant trend to a better clinical outcome in the RNAseq and Agilent microarray cohorts (p = 0.134 and p = 0.136, respectively; Fig. 4b, e). This evidence concerns the gene CD8A and neoplasm.